The deep DNA machine learning model to classify the tumor genome of patients with tumor sequencing
Keywords:
medical systems, tumor genome, tumor sequencing, DNA, genetic testing, clinical decision-making, machine learningAbstract
In general, the various medical systems currently available provide insights into changes in the tumor genome of patients with tumor sequencing. Most of the tumor DNA sequencing can also be referred to as genetic specification or genetic testing. The sequence results help clinical decision-making to develop a personalized cancer treatment plan based on the molecular characteristics of the tumor rather than a one-size-fits-all treatment approach. The tumor sequencing also plays a major role in cancer research. In this paper, an improved method based on machine learning was proposed to analyze the sequencing and tumor sequencing patterns of the human gene. This proposed method analyzes the circulatory problems of patients with different tumor types for analysis in the public domain. It also constantly monitors large data sets of cancer or tumor genetic sequences to calculate tumor size and location. This allows the doctor to get an accurate report on the type of tumor and the problems it can cause to the patient. The Analysis of these datasets of cancer tumor gene sequences reveals that the genetic makeup of each patient is different and that no two cancers are the same.
Downloads
References
Ma, B., Chai, B., Dong, H., Qi, J., Wang, P., Xiong, T., ... & Song, F. (2022). Diagnostic classification of cancers using DNA methylation of paracancerous tissues. Scientific Reports, 12(1), 1-14.
Leitheiser, M., Capper, D., Seegerer, P., Lehmann, A., Schüller, U., Müller, K. R., ... & Bockmayr, M. (2022). Machine learning models predict the primary sites of head and neck squamous cell carcinoma metastases based on DNA methylation. The Journal of Pathology, 256(4), 378-387.
Divya, S., Bhavani, Y., & Thota, M. K. (2022). A Survey on Genomic Dataset for Predicting the DNA Abnormalities Using Ml. International Journal of Advanced Computer Science and Applications, 13(5).
Das, B., & Toraman, S. (2022). Deep transfer learning for automated liver cancer gene recognition using spectrogram images of digitized DNA sequences. Biomedical Signal Processing and Control, 72, 103317.
Awamleh, Z., Chater-Diehl, E., Choufani, S., Wei, E., Kianmahd, R. R., Yu, A., ... & Weksberg, R. (2022). DNA methylation signature associated with Bohring-Opitz syndrome: a new tool for functional classification of variants in ASXL genes. European Journal of Human Genetics, 30(6), 695-702.
Tran, Q. T., Alom, M. Z., & Orr, B. A. (2022). Comprehensive study of semi-supervised learning for DNA methylation-based supervised classification of central nervous system tumors. BMC bioinformatics, 23(1), 1-17.
Logeshwaran, J., & Shanmugasundaram, R. N. (2019, December). Enhancements of Resource Management for Device to Device (D2D) Communication: A Review. In 2019 Third International conference on I-SMAC (IoT in Social, Mobile, Analytics and Cloud)(I-SMAC) (pp. 51-55). IEEE
Cho, S. B., & Won, H. H. (2003, January). Machine learning in DNA microarray analysis for cancer classification. In Proceedings of the First Asia-Pacific Bioinformatics Conference on Bioinformatics 2003-Volume 19 (pp. 189-198).
Che, H., Jatsenko, T., Lenaerts, L., Dehaspe, L., Vancoillie, L., Brison, N., ... & Vermeesch, J. R. (2022). Pan-cancer detection and typing by mining patterns in large genome-wide cell-free DNA sequencing datasets. medRxiv.
Nguyen, T. M., Le, H. L., Hwang, K. B., Hong, Y. C., & Kim, J. H. (2022). Predicting High Blood Pressure Using DNA Methylome-Based Machine Learning Models. Biomedicines, 10(6), 1406.
Chen, K., Zhang, F., Yu, X., Huang, Z., Gong, L., Xu, Y., ... & Fan, Y. (2022). A molecular approach integrating genomic and DNA methylation profiling for tissue of origin identification in lung-specific cancer of unknown primary. Journal of translational medicine, 20(1), 1-11.
Annapragada, A. V., Mathios, D., Cristiano, S., Medina, J. E., Adleff, V., Niknafs, N., ... & Scharpf, R. B. (2022). Towards population-scale screening of human cancer using genome-wide fragmentation profiles of cell-free DNA. Cancer Research, 82(12_Supplement), 5159-5159.
Logeshwaran, J., Rex, M. J., Kiruthiga, T., & Rajan, V. A. (2017, December). FPSMM: Fuzzy probabilistic based semi morkov model among the sensor nodes for realtime applications. In 2017 International Conference on Intelligent Sustainable Systems (ICISS) (pp. 442-446). IEEE
Amor, R. D., Colomer, A., Monteagudo, C., & Naranjo, V. (2022). A deep embedded refined clustering approach for breast cancer distinction based on DNA methylation. Neural Computing and Applications, 34(13), 10243-10255.
Jabari, S., Kobow, K., Pieper, T., Hartlieb, T., Kudernatsch, M., Polster, T., ... & Blümcke, I. (2022). DNA methylation-based classification of malformations of cortical development in the human brain. Acta neuropathologica, 143(1), 93-104.
Gupta, S. (2022, January). Receptor Status Prediction in Breast Cancer Patients Using Machine Learning Pipeline on DNA Methylation Data. In 2022 12th International Conference on Bioscience, Biochemistry and Bioinformatics (pp. 38-43).
Simsek, E., Badem, H., & Okumus, I. T. (2022). Leukemia Sub-Type Classification by Using Machine Learning Techniques on Gene Expression. In Proceedings of Sixth International Congress on Information and Communication Technology (pp. 629-637). Springer, Singapore.
Zhang, Q., Sun, S., Xie, Q., Wang, X., Qian, J., Yao, J., & Li, Z. (2022). FAM81A identified as a stemness-related gene by screening DNA methylation sites based on machine learning-accessed stemness in pancreatic cancer. Epigenomics, (0).
Hu, R., Zhou, X. J., & Li, W. (2022). Computational Analysis of High-Dimensional DNA Methylation Data for Cancer Prognosis. Journal of Computational Biology.
Kim, J., Yoon, Y., Park, H. J., & Kim, Y. H. (2022). Comparative Study of Classification Algorithms for Various DNA Microarray Data. Genes, 13(3), 494.
Lu, H., Liu, Y., Wang, J., Fu, S., Wang, L., Huang, C., ... & Rao, Q. (2022). Detection of ovarian cancer using plasma cell-free DNA methylomes. Clinical Epigenetics, 14(1), 1-9.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949
Attique, H., Shah, S., Jabeen, S., Khan, F. G., Khan, A., & ELAffendi, M. (2022). Multiclass Cancer Prediction Based on Copy Number Variation Using Deep Learning. Computational Intelligence and Neuroscience, 2022.
Jiang, W., Mei, W. J., Xu, S. Y., Ling, Y. H., Li, W. R., Kuang, J. B., ... & Ding, P. R. (2022). Clinical actionability of triaging DNA mismatch repair deficient colorectal cancer from biopsy samples using deep learning. EBioMedicine, 81, 104120.
Salari, K., Lee, J. J., Bicocca, V. T., Caruso, V., Mazzarella, B. C., Phillips, K. G., ... & Feldman, A. S. (2022). Comprehensive genomic profiling of urine DNA for urothelial carcinoma detection and risk prediction.
Mokoatle, M., Mapiye, D., Marivate, V., Hayes, V. M., & Bornman, R. (2022). Discriminatory Gleason grade group signatures of prostate cancer: An application of machine learning methods. PloS one, 17(6), e0267714.
Serrano Berenguer, L., Hincapié Monsalve, S., Lara Cerrillo, S., Rosado Iglesias, C., Vegas Lozano, E., Reverter Comes, F., ... & García Peiró, A. (2022). P-101 Machine and Deep learning models to classify Comet assay tests for sperm DNA fragmentation evaluation. Human Reproduction, 37(Supplement_1), deac107-097.
Tu, J., Chen, S., Wu, S., Wu, T., Fan, R., & Kuang, Z. (2022). Tumor DNA Methylation Profiles Enable Diagnosis, Prognosis Prediction, and Screening for Cervical Cancer. International Journal of General Medicine, 15, 5809.
Esfahani, M. S., Hamilton, E. G., Mehrmohamadi, M., Nabet, B. Y., Alig, S. K., King, D. A., ... & Alizadeh, A. A. (2022). Inferring gene expression from cell-free DNA fragmentation profiles. Nature Biotechnology, 40(4), 585-597.
Božić, T., Kuo, C. C., Hapala, J., Franzen, J., Eipel, M., Platzbecker, U., ... & Wagner, W. (2022). Investigation of measurable residual disease in acute myeloid leukemia by DNA methylation patterns. Leukemia, 36(1), 80-89.
Bao, H., Wang, Z., Ma, X., Guo, W., Zhang, X., Tang, W., ... & Shao, Y. (2022). An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection. Molecular cancer, 21(1), 1-7.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.